Massachusetts Securities False and Misleading Statement Attorney
Massachusetts has thousands of stock brokerage firms and investment advisory offices. With so many stock brokerage firms and investment advisory offices, comes the potential for their stockbrokers, financial advisors, and other representatives to fail to disclose material facts making the statements made about the stock, bond and other securities false and misleading and other stockbroker misconduct which violates Federal and Massachusetts securities laws and Financial Industry Regulatory Authority (FINRA) rules and stock brokerage firms policies and procedures.
For example, John Kavaler, a former Registered Representative with the Charlestown, MA branch of Ameriprise Financial Services, Inc., submitted an AWC to FINRA for allegedly making unsuitable ETN recommendations to his customers. FINRA’s findings alleged that John David Kavaler, recommended that several customers invest in a highly volatile Exchange-Traded Note (ETN), the VXX. According to FINRA, the VXX ETN is a complicated and risky investment which is unsuitable for unsophisticated investors. Mr. Kavaler, however, recommended that his customers invest in the VXX ETN without adequately explaining the risks involved or the nature of the investment. According to FINRA, based on Mr. Kavaler’s recommendations, two of his customers bought 3,500 shares of VXX for a total investment of nearly $58,000. These two customers suffered losses of more than $28,000. FINRA’s findings also state that another customer invested over $290,000 on shares of VXX and ultimately lost over $114,000. John Kavaler was assessed a deferred fine of $15,000 and suspended from association with any FINRA member for three months.Experienced Attorneys For Securities Failure to Disclose Claims In FINRA Arbitrations Throughout Massachusetts and Nationwide
Are you a Massachusetts investor who has suffered significant losses in your stock brokerage and investment accounts? Did your Massachusetts stockbroker or investment advisor fail to disclose important facts about an investment the stockbroker recommended and otherwise mismanage your investment account? If so, you will need to have representation by an experienced, highly-rated and nationally recognized FINRA arbitration securities lawyer — an attorney who knows how to handle these false and misleading statement cases as well as other complex legal issues.
By hiring a top rated securities attorney like Robert Wayne Pearce with over 40 years of experience with failure to disclose claims by practicing securities law on both sides of the table in FINRA arbitration proceedings, you will clearly see that Attorney Pearce doesn’t just handle cases—he aggressively represents investors and one of the best securities attorneys to recover your investment losses due to false and misleading statements in FINRA arbitration proceedings!
At The Law Offices of Robert Wayne Pearce, P.A., we represent investors with failure to disclose claims and all kinds of securities law and investment disputes in FINRA arbitration and mediation proceedings. We handle a wide range of practice areas such as fraud and misrepresentation, breach of fiduciary duty, failure to supervise, and unsuitable recommendations. Attorney Pearce and his staff represent investors throughout Massachusetts, and across the United States on a CONTINGENCY FEE basis, which means you pay nothing - NO FEES-NO COSTS - unless we put money in your pocket after receiving a settlement or FINRA arbitration award.
The Law Offices of Robert Wayne Pearce, P.A. are highly experienced lawyers who successfully handle failure to disclose a/k/a false and misleading statement claims and other securities law matters and investment disputes, and who work tirelessly to secure the best possible result for you and your case. For dedicated representation by an attorney with over 40 years of experience and success in failure to disclose and all kinds of securities law and investment disputes serving Massachusetts citizens, contact the firm by phone at 561-338-0037, toll free at 800-732-2889 or via e-mail.